Inflammatory and Autoimmune Conditions Causing Spinal Disc Degeneration
Ankylosing spondylitis and axial spondyloarthritis are the primary inflammatory/autoimmune conditions that cause intervertebral disc degeneration and desiccation through chronic spinal inflammation. 1, 2
Primary Inflammatory Conditions
Ankylosing Spondylitis (AS) and Axial Spondyloarthritis (axSpA)
AS is characterized by chronic inflammatory arthritis affecting the spine with sacroiliitis, enthesitis, and marked propensity for sacroiliac joint and spinal fusion. 1 The inflammatory process in AS directly impacts the intervertebral discs through several mechanisms:
Chronic inflammation leads to disc degeneration through persistent inflammatory activity in the spine, with bone marrow edema (BME) visible on MRI representing active inflammation that correlates with structural damage progression 3, 4
Inflammatory lesions at vertebral corners (corner inflammatory lesions or CILs) are associated with subsequent syndesmophyte formation and disc changes, with studies showing that vertebral edge inflammation on MRI predicts radiographic progression 4
The inflammatory cascade involves multiple cytokines including TNF-alpha, IL-1, IL-6, and IL-17, which promote extracellular matrix degradation in disc tissues 5
Nonradiographic Axial Spondyloarthritis
Patients with nonradiographic axial SpA have chronic inflammatory back pain and SpA features without radiographic sacroiliitis, but still experience disc inflammation and early degenerative changes. 1, 2 These patients demonstrate:
- Active inflammation on MRI (elevated CRP or inflammation on imaging is mandatory for biologic therapy consideration) 3
- Similar inflammatory pathways to AS, though structural damage has not yet become radiographically visible 2
Related Spondyloarthropathies
Psoriatic Arthritis (PsA)
PsA can involve axial disease with spondylitis affecting the spine in conjunction with peripheral arthritis. 5 When axial involvement occurs:
- Spinal inflammation follows similar patterns to AS with disc and vertebral involvement 5
- Approximately 30% of psoriasis patients develop PsA, and axial disease usually occurs together with peripheral arthritis 5
Inflammatory Bowel Disease-Associated Arthropathy
IBD-related spondyloarthropathy causes spinal inflammation similar to AS, with patients requiring collaborative management between rheumatology and gastroenterology 6
- Crohn's disease and ulcerative colitis are associated with axial SpA manifestations 6
- NSAIDs should be avoided in patients with active IBD as they may precipitate or exacerbate disease 6
Inflammatory Mechanisms of Disc Degeneration
Cytokine-Mediated Pathways
The inflammatory microenvironment in spondyloarthritis drives disc degeneration through specific cytokine cascades. Recent research demonstrates:
IFN-γ, IL-1β, IL-4, IL-18, GCSF, and SDF1α show causal relationships with altered disc degeneration risk through Mendelian randomization analysis 7
TNF, IL-1α, IL-1β, IL-6, and IL-17 are elevated in degenerating discs and promote extracellular matrix degradation, chemokine production, and phenotypic changes in disc cells 8
Macrophage accumulation increases with disease severity, contributing to the inflammatory cascade 9
Immune System Involvement
The breakdown of the immune-privileged status of the nucleus pulposus triggers autoimmune responses. 10 This occurs through:
- Physical barrier disruption between nucleus pulposus and systemic circulation exposes disc tissue as a foreign antigen 10
- Innervation and vascularization of degenerated discs allows immune cell infiltration 10
- Persistent inflammation at remote distances with various cytokines and immune cells involved in pain generation 10, 11
Clinical Implications
Diagnostic Considerations
MRI is essential for identifying early inflammatory disc changes before radiographic damage occurs. 12, 4
- Inflammatory back pain and HLA-B27 positivity are the best screening parameters for suspected axSpA 12
- STIR or T2-weighted fat-saturated sequences are necessary to visualize acute inflammatory findings in bone, joints, and soft tissues 13
- Gadolinium enhancement may improve conspicuity of inflammatory changes in discs, facet joints, and entheses at initial assessment 13
Treatment Implications
Early recognition and treatment of inflammatory spinal disease may prevent progressive disc degeneration. 1, 2
- NSAIDs should be used continuously (not as needed) once diagnosis is established, as they may retard long-term damage 12
- TNF inhibitors show strong efficacy for active inflammation, with 72% of patients with disease duration <10 years showing ≥50% improvement 12
- Abrogation of inflammation is presumably important to prevent structural damage, though current evidence shows TNF inhibition does not completely prevent spinal progression in established AS 14
Important Caveats
Not all disc degeneration in spondyloarthritis patients is inflammatory in origin. 3 When patients show significant changes in disease course or fail to respond to anti-inflammatory treatment:
- Consider alternative causes including mechanical disc disease, spinal fractures (common in ankylosed spines even from minor trauma), or other non-inflammatory spinal disorders 3
- Spinal fractures occur frequently in AS patients with ankylosis and may occur without preceding trauma or with neurological symptoms 3